ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,049.88
0.05%
US Tech 100
20,720.00
0.53%
Dow Jones
44,705.53
-0.17%
Brent Oil
73.595
-0.01%
Bitcoin
95,828.62
-0.15%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Celyad Oncology SA (CYAD) Quote

Celyad Oncology SA

Celyad Oncology SA (CYAD)

EU
0.762
-0.058
(-7.07%)
Closed December 03 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.762
Bid
0.761
Ask
0.808
Volume
57,706
0.76 Day's Range 0.84
0.212 52 Week Range 1.22
Market Cap
31.569M
Previous Close
0.82
Open
0.84
Last Trade
12
@
0.762
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
85,004
Shares Outstanding
41,429,000
Dividend Yield
-
PE Ratio
-3.73
Earnings Per Share (EPS)
-0.2
Revenue
102k
Net Profit
-8.45M

About Celyad Oncology SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.celyad.com
Headquarters
Mont-saint-guibert, Walloon Brabant, Bel
Founded
-
Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker CYAD. The last closing price for Celyad Oncology was 0.82 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.212 € to 1.22 €.

Celyad Oncology currently has 41,429,000 shares outstanding. The market capitalization of Celyad Oncology is 33.97 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -3.73.

Ask ADVFN Intelligence (AI)

CYAD Latest News

More News

Celyad Oncology Présentera au Congrès Annuel SITC 2024

Regulatory News: Celyad Oncology (Euronext: CYAD) (la “Société”), annonce aujourd'hui la présentation de deux posters lors de la 39e réunion annuelle de la Society for Immunotherapy of Cancer...

October 07 2024
Business Wire

Celyad Oncology announces intention to terminate SEC reporting obligations

MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with...

February 08 2024
GlobeNewswire Inc.

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...

January 16 2024
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the...

December 20 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces that 6,500,000 shares of CFIP CLYD (UK...

December 15 2023
GlobeNewswire Inc.

Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of...

December 04 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance...

December 01 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the...

November 21 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces the below information following the...

November 14 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.08212.05882352940.680.850.6371009560.74078942DE
40.393106.5040650410.3691.220.33252096330.77751078DE
120.537238.6666666670.2251.220.225850040.68115556DE
260.469160.0682593860.2931.220.212467750.61047533DE
520.382100.5263157890.381.220.212371360.52605803DE
156-2.888-79.12328767123.654.60.212408021.3706747DE
260-10.378-93.159784560111.1412.080.212422433.70448333DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ALVETEGEIRO Pharma
0.124 €
(58.97%)
481.8k
ALDVAlliance Developpement Capital Siic
0.074 €
(32.14%)
6k
MLSRPSpeed Rabbit Pizza
8.20 €
(30.16%)
19
MLSEQSequa Petroleum NV
0.011 €
(29.41%)
12k
MLCOTCoretech 5
0.01 €
(-41.18%)
200
ATOAtos SE
0.495 €
(-32.65%)
17.92M
AFMEAffluent Medical
1.20 €
(-21.05%)
21.92k
ALBIOBiosynex
2.095 €
(-18.32%)
26.9k
TRACTTeract SA
1.03 €
(-15.23%)
76.91k
BCPBanco Comercial Portugues SA
0.4457 €
(2.20%)
44.64M
ALNEVNeovacs
0.0003 €
(0.00%)
33.59M
ATOAtos SE
0.495 €
(-32.65%)
17.92M
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ORAOrange.
9.706 €
(-2.99%)
9.65M

Discussion

View Full Feed
SaltyMutt SaltyMutt 4 minutes ago
TY very much.
RKMKE RKMKE 4 minutes ago
Thats the reason these pumpers breed are not available on X...may be they don't get paid..imo
WDLF
Moonboy1 Moonboy1 5 minutes ago
I think $6.60:is the level to break.
QUBT
arizona1 arizona1 5 minutes ago
Maybe he should have fought harder when it actually mattered.
WebSlinger WebSlinger 6 minutes ago
>

Keep dreaming....

LOL

https://media.tenor.com/XpRVuVoWi5YAAAAM/haha.gif
KBLB
BestFishes BestFishes 6 minutes ago
TRILLION ENERGY SUCCESSFULLY RE-COMPLETES WELLS IN VS PROGRAM

December 3, 2024 – Vancouver, B.C. – Trillion Energy International Inc. (“Trillion”, or the “Company”) (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62) is pleased to announce that it has successfully run 2 3/8 velocity string tub
TRLEF
devil dog 96 devil dog 96 6 minutes ago
Seems that way. Her setup looks amazing 🏆️ https://www.otcmarkets.com/stock/BDPTD/security

" This stock is about to explode, isn’t it. "

https://investorshub.advfn.com/uimage/uploads/2024/12/3/fvtloScreenshot_2024-12-03_214052.jpg
BDPTD
ZenDomain85 ZenDomain85 6 minutes ago
I would argue the opposite - sell other non core assets for pennies on the dollar if needed to avoid further dilution. More dilution could quickly mean end game for FMG. A reverse stock split? For it then to decay back down to current levels most likely. Maybe run a tighter budget for 2025 and n
FFMGF
OMOLIVES OMOLIVES 8 minutes ago
No...just stating what is. For a very long time as a matter of fact. Be careful.....bank your money.....and run. Timing of your choice.
HMBL
easymonee easymonee 8 minutes ago
It has been posted multiple times that a 211 is not required to trade pink current with unsolicited quotes. An example would be SPZI, it has been trading unsolicited for the last 3 years since coming off dark....https://www.otcmarkets.com/stock/SPZI/overview. Just the facts.

GLTAL.
SPZI
MasterBlastr MasterBlastr 8 minutes ago
They would all need to buy and hold. Sticks a fork in it right there.
GDVM
getReady getReady 9 minutes ago
Truest post of the day.
HMBL
na na na na 9 minutes ago
But which entities/individuals own the warrants?

My point is that they may be able to get more people if they do another r/s, but unlikely able to get investors after another R/S after that.

They would also likely make more money if they trim the number of shares down s
THBD
abracky abracky 10 minutes ago
style="font-size: 16px"https://www.msn.com/en-us/money/topstocks/trump-says-he-ll-block-nippon-from-taking-over-us-steel-the-stock-is-falling/ar-AA1vbSFU
CLF
StockItOut StockItOut 10 minutes ago
Very subjective to claim yourself as objective.

Like Quester, you're well known for not reading the SEC filings. Or, you taking snippets of SEC filings out of context to mean other than the SEC filings state. Though when you take time you get it more often, where Quester insists his
XERI
sekander sekander 10 minutes ago
Rumor mill can only take you so far. Used to be 4,5, or even 6. Now, its 2.50-3.50.
I'm not expecting anything until Jan.20 at the earliest. Relax. All the rest is just hypsters
and traders noise.
FNMA
StayHumble StayHumble 11 minutes ago
Full YEAR SALES $55M+Up90%💹💹GrossProfit $20M+Up 99%💹💹
https://www.healthiercmc.com/news/240327-hcmc-q4-2023-results
HCWC
fwb fwb 11 minutes ago
My old man told me when I was a kid
If you don't have the STONES (he used another word) to be in the fight, don't get in the ring.
Well if people don't have the STONES to be in NVDA (BUY STOCK) maybe they should not get in the Stock market.
If you are afraid to lose money, go bu
NVDA
MrBoomtown MrBoomtown 12 minutes ago
#DEVS $DEVS -I'VE BEEN TAKING A BIT OF A Shellacking THE PAST FEW DAYS ON THIS One. I'm going to ride it out and buy a bit more. Do your own due diligence.
DEVS
Bolster Bolster 12 minutes ago
Gosh Bever is it true?
AITX
doc2016 doc2016 13 minutes ago
kona,

cruz patent? photonics.....nkt/hamamatsu twisted light/radisys and tektronix laser mirror calibration work/ but is the trapped ion therefore the cruz instrument in the patent?
IONQ
Lakota-45 Lakota-45 13 minutes ago
Yep - I saw that post !
INQD
ANTI-BAGHOLDER ANTI-BAGHOLDER 14 minutes ago


It's amazing how intriguing this story continues to beco
MONI
dealerschool2006 dealerschool2006 14 minutes ago
$XRP has been doing well last couple weeks...SEC lost their case against Ripple...
XRP

Your Recent History

EU
CYAD
Celyad Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved